Territory Sales Manager
Revvity
William has been representing Revvity Mimix reference material for 4 years and has been integral in the development and design of new and custom controls keeping in line with market trends and direction. Most notable he has been directly involved in design and development of our new enzymatically fragmented ctDNA suspended in DNA depleted plasma. This new ctDNA product is the most analogous to patient material of any commercially available oncology focused clinical refernce material.